'
Advanced Enzymes Technologies conducted conference call on 14 May 2025 to discuss the financial results and performance of the company for the quarter ended March 2025. Mr. Mukund Kabra – Whole-time Director and Mr. Beni Prasad Rauka - Chief Financial Officer along with other senior management of the company addressed the call
Highlights of the Concall
- The global economy is experiencing moderate growth amid persistent challenges. The volatile growth is attributed to factors such as high depth levels, weak investment and ongoing geopolitical tensions including trade disputes involving major economics like the US China and the European Union
- The company has filed a food enzyme dossier to the European Food Safety Authority for approval. The enzyme is intended for application in baking and the production of refined edible fats and oils. In the United States two GRAS (generally recognized as safe) dossiers have been filed with the US FDA supporting...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
(09-Feb-2023)
Mayur Uniquoters
Targets revenue of Rs 1000 crore in FY24
-
(31-Jan-2023)
Tega industries
Capex plan is US$ 30-32 million for next three years
|